Comparing famotidine and antacids for treating dyspepsia
Official title: Comparing Intravenous Famotidine and Oral Antacids in the Treatment of Dyspepsia in the Emergency Department
Run by Stony Brook University · NCT06241183 · Data updated 2026-11-12
This study is testing whether an IV medication called famotidine works better than an antacid for quickly relieving stomach pain in people with dyspepsia who come to the emergency room.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Stony Brook University Academic / other |
| Locations | 1 site (Stony Brook, New York) |
| Status | Recruiting |
| Started | November 9, 2023 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 2, 2026 |
| Trial ID | NCT06241183 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who present to the emergency department with dyspepsia and a pain score of at least 3.
✕Probably not a fit
Patients with hypersensitivity to the study medications, severe renal insufficiency, or those who are pregnant or nursing may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the effectiveness of intravenous famotidine, an H2 receptor antagonist, with oral Maalox/Mylanta, an antacid, in treating dyspepsia symptoms in patients presenting to the emergency department. Approximately 80 patients will be randomized into two groups to receive either treatment, and their pain levels will be assessed using a verbal numeric pain scale at multiple time points after administration. The study seeks to determine which treatment provides faster and more significant relief from pain associated with dyspepsia.
Why it matters
Potential benefit: If successful, this study could provide insights into more effective treatment options for patients suffering from dyspepsia.
How similar studies have gone: Previous studies have indicated that antacids may provide quicker symptom relief compared to H2 receptor antagonists, suggesting a potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subject Age ≥ 18 years of age 2. Patient diagnosed with dyspepsia 3. Present at the ED with upper abdominal pain score of at least 3 Exclusion Criteria: 1. Hypersensitivity to an ingredient in Maalox/ Mylanta or Famotidine 2. Moderate to Severe Renal Insufficiency (precaution) 3. Kidney Failure 4. Pregnant or Nursing 5. Verbal pain score less than 3 6. Inability to tolerate oral medications 7. Bowel Obstruction 8. Proton pump inhibitor within 2 hours of study treatment
Where it's running
-
Stony Brook University Hospital
Stony Brook, New York, United States Recruiting
Study contacts
- Study coordinator: Adam Singer, MD
- Email: adam.singer@stonybrookmedicine.edu
- Phone: 6314447857
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Thread-Embedding Acupuncture plus a Proton Pump Inhibitor for GERD
This study tests whether adding thread-embedding acupuncture to standard omeprazole treatment helps people with GERD who have a traditional Liver-Stomach constraint-heat pattern.
-
Virtual poetry workshops to boost well-being for people with digestive symptoms
This study tests whether participating in online poetry workshops can improve emotional well-being for adults with chronic digestive symptoms and anxiety or depression.
-
Transoral incisionless fundoplication (TIF) for GERD in Asian adults
This tests whether a less-invasive transoral incisionless fundoplication (TIF) procedure can reduce reflux symptoms in Asian adults who continue to have GERD despite daily PPI treatment.
-
Diaphragm training for GERD symptoms
This study will test whether diaphragm-focused breathing exercises or using a volume-based incentive spirometer can help people with GERD have fewer reflux episodes and better symptoms.
-
Symptoms and quality of life in people with gastric inlet patches
This study will see if adults having a medically indicated gastroscopy who have heterotopic gastric mucosa (gastric inlet patches) are more likely to have swallowing problems, indigestion, or lower quality of life than those without it.
-
A registry for adults with esophageal movement and reflux problems.
This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.